- Country: Croatia
- Summary: Joint Procurement of Special Drug Groups
- HRT Ref No: 118444472
- Deadline: 09 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 1698607.68
- Notice Type: Tender
- Document Ref. No.: 281045-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of procurement is special groups of medicines for 28 health institutions in the Republic of Croatia.
Pursuant to Article 203. ZJN 2016 the subject of procurement is divided into 92 groups of procurement items (Group 1 - 92).
In accordance with Article 204. Paragraph 3For all groups of procurement objects.
Procurement of special groups Drugs
5
7
10
11
21
22
19
29
30
35
36
37
38
39
44
45
46
47
48
49
50
51
52
53
57
62
63
67
71
72
76
77
78
79
83
84
85
86
87
88
89
90
91
DocTitle: Common Procurement of Special Gruzing Drugs
Contract Type: Supplies - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINJoint Procurement of Special Drug Groups - Croatia Tender
The CROATIAN HEALTH INSURANCE INSTITUTE, a Government sector organization in Croatia, has announced a new tender for Joint Procurement of Special Drug Groups. This tender is published on CroatiaTenders under HRT Ref No: 118444472 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-09.
The estimated tender value is EUR 1698607.68, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
